
Biocartesian
Converting biology into digital molecular maps
San Francisco, US
Hard TechB2BBiotechDiagnosticsDrug discovery
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Meet the team2
The people behind Biocartesian
Ian Dardani
Founder
Jess Li
Founder